Rehabilitative Strategies Following Oesophageal Cancer
NCT03314311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2017-10-19
Summary
The ReStOre trial is a multi-disciplinary intervention of exercise, diet and education for patients who have completed treatment for oesophageal cancer. The intervention aims to improve quality of life and functional performance following oesophageal cancer and assist patients to return to normal activity during the early survivorship phase. The 12-week intervention will involve structured exercise training, individual dietary advice and multi-disciplinary education sessions addressing a range of survivorship needs.
Conditions
- Esophageal Cancer
Interventions
- BEHAVIORAL
-
Rehabilitation programme
The RESTORE trial is a 12 week multi-disciplinary intervention involving exercise, nutrition advice and education sessions
Sponsors & Collaborators
-
University College Dublin
collaborator OTHER -
University of Dublin, Trinity College
lead OTHER
Principal Investigators
-
Juliette Hussey, PhD · University of Dublin, Trinity College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- Ireland
Study Locations
More Related Trials
-
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
NCT00978549 ·Status: COMPLETED ·Phase: PHASE3
-
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
NCT03274349 ·Status: UNKNOWN ·Phase: NA
-
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
NCT03396614 ·Status: COMPLETED
-
Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery
NCT02335970 ·Status: COMPLETED ·Phase: NA
-
Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients
NCT02323776 ·Status: TERMINATED
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002631 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
NCT05563766 ·Status: RECRUITING ·Phase: PHASE2
-
International Nutrition Audit in FORegut TuMors
NCT02829489 ·Status: COMPLETED
-
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003321 ·Status: COMPLETED
-
Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose
NCT02130011 ·Status: COMPLETED ·Phase: NA
-
PDL-1 Targeting in Resectable Oesophageal Cancer
NCT03087864 ·Status: COMPLETED ·Phase: PHASE2
-
Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery
NCT02234180 ·Status: TERMINATED ·Phase: PHASE2
-
Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer
NCT02415101 ·Status: COMPLETED ·Phase: NA
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
M6620 Plus Standard Treatment in Oesophageal and Other Cancer
NCT03641547 ·Status: COMPLETED ·Phase: PHASE1
-
OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma
NCT03429816 ·Status: COMPLETED ·Phase: NA
-
Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
NCT03474341 ·Status: UNKNOWN
-
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
NCT03462524 ·Status: COMPLETED
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 ·Status: TERMINATED ·Phase: PHASE2
-
Liquid Biopsies in Esophageal Cancer
NCT05704530 ·Status: RECRUITING ·Phase: NA
-
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
NCT00109850 ·Status: TERMINATED ·Phase: PHASE2
-
Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.
NCT02241499 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
NCT00037089 ·Status: UNKNOWN ·Phase: PHASE2
-
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
NCT00100945 ·Status: COMPLETED ·Phase: PHASE2